Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Oramed Pharm (ORMP) just unveiled an update.
Oramed Pharmaceuticals Inc. has announced the appointment of Mr. Avraham Gabay as the new Chief Financial Officer, Treasurer, and Secretary, set to begin on June 18, 2024. Gabay brings a wealth of experience, having previously held financial leadership roles at BiomX Inc., Oravax Inc., and other notable firms. He is also a certified public accountant and a member of the Israeli Bar Association. His compensation includes a monthly salary, bonuses, equity grants, and a company car, all determined by the company’s Board of Directors and Compensation Committee.
For a thorough assessment of ORMP stock, go to TipRanks’ Stock Analysis page.
